A Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis

NCT03627052 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Study withdrawn due to lack of recruitment. No patients enrolled. No safety concerns.

Conditions

Interventions

Sponsor

Incyte Corporation